CIK 0001515673 · Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272546083
- Phone
- 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-18 | WELCH DANIEL G Director | Grant or award | +5,345 | 26,950 | ||
| 2024-06-18 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-06-18 | NARACHI MICHAEL Director | Grant or award | +5,345 | 26,950 | ||
| 2024-06-18 | NARACHI MICHAEL Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-06-18 | Ray Amrit Director | Grant or award | +5,345 | 17,625 | ||
| 2024-06-18 | Ray Amrit Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-06-18 | Sanders Corazon (Corsee) D. Director | Grant or award | +5,345 | 12,593 | ||
| 2024-06-18 | Sanders Corazon (Corsee) D. Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-06-18 | SULIMAN SHEHNAAZ Director | Grant or award | +5,345 | 20,200 | ||
| 2024-06-18 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) | +9,900 | 9,900 | ||
| 2024-06-12 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale 10b5-1 | −9,806 | $45.00 | $441K | 57,981 |
| 2024-06-10 | Sanders Corazon (Corsee) D. Director | Sale 10b5-1 | −1,737 | $41.10 | $71K | 7,248 |
| 2024-05-02 | Crombez Eric EVP and Chief Medical Officer | Sale | −354 | $43.66 | $15K | 48,431 |
| 2024-04-18 | Crombez Eric EVP and Chief Medical Officer | Sale | −142 | $44.10 | $6K | 48,785 |
| 2024-04-16 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Shares withheld for taxes | −14 | $42.31 | $592 | 41,366 |
| 2024-03-11 | Kassberg Thomas Richard CBO & EVP | Sale | −11,509 | $49.93 | $575K | 252,823 |
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −2,550 | $50.89 | $130K | 24,505 |
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −2,145 | $50.85 | $109K | 22,360 |
| 2024-03-07 | Fust Matthew K Director | Sale 10b5-1 | −7,500 | $50.88 | $382K | 14,860 |
| 2024-03-01 | Horn Howard Chief Financial Officer | Grant or award | +19,400 | 99,766 |
Page 8 of 11 · 204 trades